Related Experiment Video
Updated: Apr 21, 2026
08:35
Application of DNA Fingerprinting using the D1S80 Locus in Lab Classes
Published on: July 17, 2021
22.4K
Plasma tumor DNA: on your markers, get set, go!
11 The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA ; 2 The Whiting School of Engineering, Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD, USA.
Annals of Translational Medicine
|October 22, 2014
Summary
Plasma tumor DNA (ptDNA) shows promise as a reliable biomarker for monitoring metastatic breast cancer treatment response. This liquid biopsy approach offers prognostic significance and improved disease management, though further research is needed.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Metastatic breast cancer (MBC) is a complex disease requiring effective monitoring for treatment efficacy.
- Current monitoring methods can be invasive or lack sensitivity in reflecting dynamic disease changes.
- Endocrine, HER2-targeted, and chemotherapy regimens improve survival but necessitate precise response assessment.
Purpose of the Study:
- To evaluate the potential of plasma tumor DNA (ptDNA) as a sensitive biomarker for MBC.
- To assess the prognostic value and dynamic monitoring capabilities of ptDNA in patients with metastatic breast cancer.
- To explore the clinical utility of ptDNA liquid biopsies in managing MBC.
Main Methods:
- Analysis of ptDNA levels in blood samples from patients with metastatic breast cancer.
- Correlation of ptDNA levels with treatment response and patient survival.
- Assessment of ptDNA sensitivity and dynamic range as a biomarker.
Main Results:
- ptDNA demonstrated high sensitivity and a wide dynamic range, serving as a reliable biomarker in metastatic breast cancer.
- Absolute ptDNA levels showed significant prognostic value.
- ptDNA levels more accurately reflected changes in response to therapy compared to conventional methods.
Conclusions:
- ptDNA liquid biopsy is a promising tool for monitoring disease burden and treatment response in metastatic breast cancer.
- Further technical optimization and large-scale clinical validation are required for widespread adoption.
- ptDNA has the potential to significantly improve the clinical management of metastatic breast cancer patients.
Related Concept Videos
01:29Modern Molecular Taxonomy
828
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
828
02:05DNA as a Genetic Template
22.0K
Two structural features of the DNA molecule provide a basis for the mechanisms of heredity: the four nucleotide bases and its double-stranded nature. The Watson-Crick model of double-helical DNA structure, proposed in 1952, drew heavily upon the X-ray crystallography work of researchers Rosalind Franklin and Maurice Wilkins. Watson, Crick, and Wilkins jointly received the Nobel Prize in Physiology or Medicine for their work in 1962. Franklin was, controversially, excluded from the prize for...
22.0K
02:05DNA as a Genetic Template
7.4K
7.4K
01:17Karyotyping
48.9K
Overview
48.9K
03:31Labeling DNA Probes
7.7K
DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
7.7K
02:34DNA Microarrays
16.5K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
16.5K